Soluble epoxide hydrolase inhibition Promotes White Matter Integrity and Long-Term Functional Recovery after chronic hypoperfusion in mice

about

Soluble epoxide hydrolase inhibition Promotes White Matter Integrity and Long-Term Functional Recovery after chronic hypoperfusion in mice

Item

http://www.wikidata.org/entity/Q41354081

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Soluble epoxide hydrolase inhi ...... chronic hypoperfusion in mice

@en

type

Item

label

Soluble epoxide hydrolase inhi ...... chronic hypoperfusion in mice

@en

prefLabel

Soluble epoxide hydrolase inhi ...... chronic hypoperfusion in mice

@en

P1476

Soluble epoxide hydrolase inhi ...... chronic hypoperfusion in mice

@en

P2093

Ensheng Yao

http://www.w3.org/2001/XMLSchema#string

Hao Tian

http://www.w3.org/2001/XMLSchema#string

Huaqiu Zhang

http://www.w3.org/2001/XMLSchema#string

Li Xu

http://www.w3.org/2001/XMLSchema#string

Minjie Xie

http://www.w3.org/2001/XMLSchema#string

Peng Du

http://www.w3.org/2001/XMLSchema#string

Wei Wang

http://www.w3.org/2001/XMLSchema#string

Yeye Tian

http://www.w3.org/2001/XMLSchema#string

Yongkang Fang

http://www.w3.org/2001/XMLSchema#string

Yuxue Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Soluble epoxide hydrolase activity regulates inflammatory responses and seizure generation in two mouse models of temporal lobe epilepsy

Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges

The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases

Soluble epoxide hydrolase gene deletion is protective against experimental cerebral ischemia

Soluble epoxide hydrolase: a novel therapeutic target in stroke

Soluble Epoxide Hydrolase Inhibition: Targeting Multiple Mechanisms of Ischemic Brain Injury with a Single Agent

Epoxyeicosanoid signaling in CNS function and disease

Oral treatment of rodents with soluble epoxide hydrolase inhibitor 1-(1-propanoylpiperidin-4-yl)-3-[4-(trifluoromethoxy)phenyl]urea (TPPU): Resulting drug levels and modulation of oxylipin pattern

1,026 experimental treatments in acute stroke

Soluble epoxide hydrolase is a therapeutic target for acute inflammation

P2888

s41598-017-08227-z

P304

7758

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-017-08227-Z

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-08-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1091143782

http://www.w3.org/2001/XMLSchema#string

P698

28798352

http://www.w3.org/2001/XMLSchema#string

P932

5552839

http://www.w3.org/2001/XMLSchema#string